Fortitude Biomedicines is a biotechnology company that develops antibody-based biologic drugs targeting autoimmune diseases.
Fortitude Biomedicines has raised $13.0M in total funding. The most recent round was Seed. The last funding was announced in January 2026.
Fortitude Biomedicines's investors include K2VC, Taihill Venture, Shanghai Biomedical Industrial Equity Investment Fund, Yijing Capital, Elikon Venture.
Fortitude Biomedicines is headquartered in Waltham, United States.
Fortitude Biomedicines is a biotechnology company that develops antibody-based biologic drugs targeting autoimmune diseases.
Fortitude Biomedicines is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fortitude Biomedicines — Funding & Investors." VCBacked, January 26, 2026, https://www.vcbacked.co/company/fortitude-biomedicines. Accessed October 23, 2026.
VCBacked. (2026). Fortitude Biomedicines — Funding & Investors. Retrieved October 23, 2026, from https://www.vcbacked.co/company/fortitude-biomedicines
{{cite web |title=Fortitude Biomedicines — Funding & Investors |url=https://www.vcbacked.co/company/fortitude-biomedicines |website=VCBacked |access-date=October 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated